| |
 |
Jeno Korosi Patents |
|
Inventor: Korosi; Jeno
Address: Budapest, HU
No. of patents: 15
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| RE30014 |
1-(3,4-Dimethoxy-phenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5H-2,3- benzodiazepine |
May 29, 1979 |
| 1-(3,4-DIMETHOXY-PHENYL)-4-METHYL-5-ETHYL-7,8-DIMETHOXY-5H-2,3-.Iadd.benzo. Iaddend.diazepine having the following formula ##STR1## This new compound is non-toxic and pharmacologically active. Its acid addition salts also have useful pharmacological |
| 5639751 |
N-acyl-2,3-benzodiazepine derivatives for treating acute and chronic neurodegenerative disorders |
June 17, 1997 |
| The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I)R stands for a C.sub.1-6 alkanoyl group |
| 5604223 |
N acyl 2 3 benzodiazepine derivatives pharmaceutical compositions containing them and process fo |
February 18, 1997 |
| The invention relates to novel N-acyl-2,3-benzodiazepine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I), defined in this specification, a |
| 5536832 |
N-acyl-2,3-benzodiazepine derivatives pharmaceutical compositions containing them and process fo |
July 16, 1996 |
| The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I)R stands for a C.sub.1-6 alkanoyl group |
| 5521174 |
N-acyl-2,3-benzodiazepine derivatives and a method of treating spasms of the skeletal musculatur |
May 28, 1996 |
| The invention relates to novel N-acyl-2,3-benzodiezapine derivatives and a method of treating spasms of the skeletal musculature therewith. |
| 5519019 |
N-acyl-2,3-benzoidazepine derivatives, pharmaceutical compositions containing them and process f |
May 21, 1996 |
| The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I)R stands for a C.sub.1-6 alkanoyl group |
| 5459137 |
N-acyl-2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and process f |
October 17, 1995 |
| The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I), defined in the specification, a m |
| 5288863 |
Process for the preparation of high-purity 1-(3-chloro-phenyl)-4-methyl-7,8-dimethoxy-5H-2,3-ben |
February 22, 1994 |
| The invention relates to a process for the preparation of 1-(3-chlorophenyl)-4-methyl-7,8-dimethoxy-5 H-2,3-benzodiazepine of formula (I) ##STR1## in high purity and in a quality suitable for pharmaceutical purposes. According to the invention the reaction of 1 mole of 2-acet |
| 5204343 |
5H-benzodiazepin derivative |
April 20, 1993 |
| The invention relates to the new 1-(3-chlorophenyl)-4-hydroxymethyl-7,8-dimethoxy-5H-2,3-benzodiazepine of formula (I) ##STR1## and pharmaceutically acceptable acid addition salts thereof, furthermore to a process for preparing these compounds.The compounds according to the inven |
| 4840948 |
1-(hydroxystyrl)-5H-2,3-benzodiazepine derivatives, and pharmaceutical compositions containing t |
June 20, 1989 |
| This invention relates to new 1-(hydroxystyryl)-5H-2,3-benzodiazepine derivatives of the general formula (I) and to a process for the preparation thereof, furthermore to pharmaceutical compositions containing the same, ##STR1## wherein R stands for a hydrogen or halogen atom, or |
| 4835152 |
1-(4-Aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3-b enzodiazepine and acid additio |
May 30, 1989 |
| The invention relates to new 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3-benzodiaz epi ne of formula (1), optically active isomers and acid addition salts thereof as well as to pharmaceutical compositions containing these compounds. ##STR1## The new compou |
| 4785104 |
3-(hydroxymethyl)-isoquinoline derivatives |
November 15, 1988 |
| This invention relates to new 3-(hydroxymethyl)-isoquinoline derivatives of the general formula (I), their acid addition salts, and to a process for the preparation thereof, furthermore to pharmaceutical compositions containing the same, ##STR1## wherein R and R.sup.1 are identic |
| 4614740 |
5H-2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same |
September 30, 1986 |
| The invention relates to new 5H-2,3-benzodiazepine derivatives and a process for the preparation thereof, furthermore to pharmaceutical compositions containing the same.The new 5H-2,3-benzodiazepine derivatives of the invention possess valuable central nervous effect and in particular ex |
| 4423044 |
3,4-Dihydro-5H-2,3-benzodiazepine derivatives and pharmaceutical use thereof |
December 27, 1983 |
| The invention relates to new 3,4-dihydro-5H-2,3-benzodiazepine derivatives of general formula (I) and pharmaceutically acceptable acid addition salts thereof, ##STR1## wherein R represents a phenyl group optionally carrying one or two substituents selected from the group consisti |
| 4322346 |
5H-2,3-Benzodiazepine derivatives |
March 30, 1982 |
| New 5H-2,3-benzodiazepine derivatives of the formula ##STR1## wherein R is phenyl having a trifluoromethyl or halogen substituent,R.sup.1 is methyl,R.sup.2 is hydrogen,R.sup.3 is methoxy and R.sup.4 is methoxy, and the pharmaceutically acceptable acid addition salts thereof, are potent t |
|
|
|
